|
Rotating shift work may raise irritable bowel risk
NEW YORK (Reuters Health) - Rotating shift work can wreak havoc with bodily functions such as sleep and bowel movements. Now study findings hint that rotating work schedules may also increase risk for irritable bowel syndrome.
www.delta-optimist.com
Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD)
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial fo
finance.yahoo.com
Gazette.Net: Constipation drug offers more potential for Bethesdas Sucampo
After a successful phase 3 clinical trial, Sucampo Pharmaceuticals of Bethesda is ready to apply for U.S. regulatory approval to market its constipation drug to people who have bowel dysfunction from taking morphine and codeine for chronic, non-cancer pain.
www.gazette.net
Sucampo Pharma's Lubiprostone Meets Key Goal In Phase III Trial For OBD - Update
Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.
www.rttnews.com
Sucampo Pharma's Laxative Meets Key Goal In Phase III Trial For OBD - Update
Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.
www.rttnews.com
Common Gastro Disease Occurs Even With High-Fiber Diet
FRIDAY, Jan. 27 (HealthDay News) -- Eating a high-fiber diet does not lower a person's risk of diverticulosis, but a low-fiber diet might, according to a new study that contradicts what doctors have believed for decades.
news.yahoo.com
Children's bed-wetting may be caused by constipation
Some children who wet their bed might be suffering from constipation, a new study finds
www.foxnews.com
Press Release
Sucampo Pharmaceuticals Inc. Posted on:02 Feb 12 Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone.
www.pharmiweb.com
ASK A DOCTOR
Q: What causes hemorrhoids?
www.timesfreepress.com
Woman dies after cancer goes untreated
Just a month before Elizabeth Howan died of bowel cancer, doctors were telling her the chronic pains she suffered for more than six years were in her head.
www.stuff.co.nz
|
